Principal Investigators Lorelei Mucci, ScD, MPH (Harvard T.H. Chan School of Public Health), and Daniel George, MD (Duke University) were named recipients of a 2022 Prostate Cancer Foundation (PCF) Challenge Award for their proposal, IRONMAN: Enhancing Survivorship in Patients with Advanced Prostate Cancer. The IRONMAN Registry (ClinicalTrials.gov Identifier: NCT03151629) is managed by the Prostate Cancer Clinical Trials Consortium (PCCTC).
Survivorship is a field of oncology which aims to understand and improve quality of life in patients living with or after cancer. Drs. Mucci, George, and team’s project focuses on understanding patients’ cancer experience and quality of life, their prognosis, and treatment disparities. These findings will inform practice, identify unmet needs, reduce disparities, and identify strategies for advanced prostate cancer patients to flourish. Details of the proposal were outlined by PCF:
If successful, this IRONMAN project will identify relationships between clinical, demographic, and lifestyle factors, and patient quality of life and outcomes. This will enable the identification of strategies for improving quality of life, extending survival, and reducing health disparities for patients with advanced prostate cancer.
For more information on IRONMAN visit https://ironmanregistry.org/
To learn more about the 2022 PCF Challenge Awards visit https://www.pcf.org/c/challenge-awards-class-of-2022/
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.